Cortice Biosciences Inc. 13D and 13G filings for CNS Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-08-02 4:11 pm Purchase |
2024-07-29 | 13D | CNS Pharmaceuticals, Inc. CNSP |
Cortice Biosciences Inc. | 11,467 5.700% |
11,467 (New Position) |
Filing |